Tuba ÖZCAN METİN, Ayşe Ayça SARI, Bahar TAŞDELEN, Erdem DİNÇ, Banu ÇOŞKUN YILMAZ, Emin Serbülent GÜÇLÜ

Efficacy of mitomycin-C and infliximab in reducing adhesionand fibrosis following strabismus surgery

Background/aim: The present study aimed to investigate the efficacy of mitomycin-C (MMC) and infliximab (INF) in reducing adhesion and fibrosis following strabismus surgery. Materials and methods: Forty eyes of 20 albino rabbits were separated into MMC and INF groups. Right and left eyes of rabbits were assigned to the drug and control groups, respectively. The superior rectus muscle was disinserted, the drug was administered to the surgical area for 5 min in the drug eyes (MMC 0.2 mg/mL or INF 5 mg/mL), and physiological saline was administered to the control eyes. Surgical areas were rinsed with 10 mL of physiological saline. The disinserted muscle was then sutured to the same area using 6.0 Vicryl. The rabbits were sacrificed after 4 weeks for histopathological examination. Results: Significant reduction was observed in fibrosis in the INF group as compared to the control group (P = 0.005). Although adhesion formation in the drug eyes reduced in the MMC and INF groups as compared to the control group, the difference was not significant (P = 0.280 and P = 0.579, respectively). Conclusion: This study demonstrated the fibrosis-preventing efficacy of IFN; thus, it can be a good option in reducing fibrosis in strabismus surgery.

PDF

___

1. Ludwig IH. Scar remodeling after strabismus surgery. Trans Am Ophthalmol Soc 1999; 97: 583-651.
2. Dunlap EA. Surgery of muscle adhesions and effects of multiple operations. Br J Ophthalmol 1974; 58: 307-312.
3. Simon JW. Complications of strabismus surgery. Curr Opin Ophthalmol 2010; 21: 361-366.
4. Choi HY, Lee JH, Lee JE, Jung JH. Effect of bevacizumab on strabismus surgery in rabbits. Invest Ophthalmol Vis Sci 2010; 51: 4585-4588.
5. Ryu WY, Jung HM, Roh MS, Kwon YH, Jeung WJ, Park WC, Rho SH, Ahn B. The effect of a temperature-sensitive poloxamer-alginate-CaCl2 mixture after strabismus surgery in a rabbit model. J AAPOS 2013; 17: 484-489.
6. Dunlap EA. Plastic implants in muscle surgery: a study of the possible use of plastic materials in the management of extraocular motility restrictions. Trans Am Ophthalmol Soc 1967; 65: 393-470.
7. Sondhi N, Ellis FD, Hamed LM, Helveston HM. Evaluation of an absorbable muscle sleeve to limit postoperative adhesions in strabismus surgery. Ophthalmic Surg 1987; 18: 441-443.
8. Sondhi N, Koseoglu ST, Bonnin JM, Fahad B. Polydiaxonon prevents adhesions in the rabbit model: a pilot report. J AAPOS 1998; 2: 214-217.
9. Hwang JM, Chang BL. Delayed reattachment of extraocular muscles in rabbits using thin polytetrafluoroethylene. Ophthalmic Surg Lasers 1997; 28: 59-64.
10. Ozkan SB, Kir E, Culhaci N, Dayanir V. The effect of Seprafilm on adhesions in strabismus surgery-an experimental study. J AAPOS 2004; 8: 46-49.
11. Hwang JM, Chang BL. Use of physical barriers for delayed adjustable strabismus surgery: the effect of Interceed and polyglactin 910 mesh. Br J Ophthalmol 1996; 80: 759-762.
12. Choung HK, Hwang JM. The use of Surgi Wrap in delayed adjustable strabismus surgery. Am J Ophthalmol 2005; 140: 433-436.
13. Fulga V, Koren R, Ezov N, Gal R, Nimrod A, Savir H. Sodium hyaluronate as a tool in strabismus surgery in rabbits. Ophthalmic Surg Lasers 1996; 27: 228-233.
14. Ferreira RC, Lamberts M, Moreira JB, Campos MS. Hydroxypropylmethylcellulose and sodium hyaluronate in adjustable strabismus surgery. J Pediatr Ophthalmol Strabismus 1995; 32: 239-242.
15. de Carvalho LE, Alves MR, da Silva MA, Gaal Vadas MF. Experimental strabismus surgery using triamcinolone: outcomes and effects on inflammatory response. Arq Bras Oftalmol 2007; 70: 209-215.
16. Strube YN, Conte F, Faria C, Yiu S, Wright KW. Amniotic membrane transplantation for restrictive strabismus. Ophthalmology 2011; 118: 1175-1179.
17. Demirel S, Atilla H, Okcu Heper A, Erkam N. Effects of amniotic membrane on wound healing and adhesions in experimental strabismus surgery. Eur J Ophthalmol 2009; 19: 899-904.
18. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003; 48: 314-346.
19. Eşme A, Yildirim C, Tatlipinar S, Düzcan E, Yaylali V, Ozden S. Effects of intraoperative sponge mitomycin C and 5-fluorouracil on scar formation following strabismus surgery in rabbits. Strabismus 2004; 12: 141-148.
20. Abraham LM, Selva D, Casson R, Leibovitch I. Mitomycin: clinical applications in ophthalmic practice. Drugs 2006; 66: 321-340.
21. Onol M, Aktaş Z, Hasanreisoğlu B. Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application. Clin Experiment Ophthalmol 2008; 36: 316-322.
22. Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctivalcorneal intraepithelial neoplasia. Am J Ophthalmol 2004; 137: 950-951.
23. Yildirim C, Yaylali V, Esme A, Ozden S. Long-term results of adjunctive use of mitomycin C in external dacryocystorhinostomy. Int Ophthalmol 2007; 27: 31-35.
24. Urban RC Jr, Kaufman LM. Mitomycin in the treatment of hypertrophic conjunctival scars after strabismus surgery. J Pediatr Ophthalmol Strabismus 1994; 31: 96-98.
25. Cruz OA, Matkovich L. Effects of intraoperative topical mitomycin-C on strabismus surgery in the rabbit: a preliminary study. Ophthalmic Surg 1995; 26: 237-240.
26. Cruz OA. Evaluation of mitomycin to limit postoperative adhesions in strabismus surgery. J Pediatr Ophthalmol Strabismus 1996; 33: 89-92.
27. Chen PL, Chen WY, Lu DW. Evaluation of mitomycin C in reducing postoperative adhesions in strabismus surgery. J Ocul Pharmacol Ther 2005; 21: 406-410.
28. Kersey JP, Vivian AJ. Mitomycin and amniotic membrane: a new method of reducing adhesions and fibrosis in strabismus surgery. Strabismus 2008; 16: 116-118.
29. Minguini N, Monteiro de Carvalho KM, Akaishi PM, De Luca IM. Histologic effect of mitomycin C on strabismus surgery in the rabbit. Invest Ophthalmol Vis Sci 2000; 41: 3399-3401.
30. Brooks SE, Ribeiro GB, Archer SM, Elner VM, Del Monte MA. Fat adherence syndrome treated with intraoperative mitomycin-C: a rabbit model. J Pediatr Ophthalmol Strabismus 1996; 33: 21-27.
31. Uçar D, Ocakoğlu Ö, Solakoğlu S. Histological evaluation of local TNF alpha inhibition on conjunctiva and tenon fibroblastic activity in surgical wound healing of rabbit eyes (experimental prestudy). Turk J Ophthalmol 2009; 39: 197-204 (in Turkish with English abstract).
32. Takamoto M, Kaburaki T, Numaga J, Fujino Y, Kawashima H. Long-term infliximab treatment for Behçets disease. Jpn J Ophthalmol 2007; 51: 239-240.
33. Suhler EB, Smith JR, Wertheim MS, Lauer AK, Kurz DE, Pickard TD, Rosenbaum JT. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 2005; 123: 903-912.
34. Ali A, Samson CM. Seronegative spondyloarthropathies and the eye. Curr Opin Ophthalmol 2007; 18: 476-480.
35. Mangge H, Heinzl B, Grubbauer HM, El-Shabrawi Y, Schauenstein K. Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis. Rheumatol Int 2003; 23: 258-261.
36. Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm 2007; 15: 99-104.
37. Durrani OM, Reuser TQ, Murray PI. Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy. Orbit 2005; 24: 117-119.
38. Li Z, Choi W, Oh HJ, Yoon KC. Effectiveness of topical infliximab in a mouse model of experimental dry eye. Cornea 2012; 31: 25-31.
39. Ferrari G, Bignami F, Giacomini C, Franchini S, Rama P. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. Invest Ophthalmol Vis Sci 2013; 54: 1680- 1688.